RE:RE:RE:RE:RE:RE:Capacity now for new customers as targeted"Gilles rode the base business - it was demand from products, NOT his 'work'"
More smearing of Gilles and this time with an account created only 11 days ago. Symrise has said it sees "great value" in its "long standing" "product development" "relationship" with CZO and that the agreement is expected to pave the way for future developments.
“Ceapro and Symrise have a long-standing relationship in product development that has benefitted both companies over the years,” said Joern Andreas, President Cosmetic Ingredients Division, Symrise AG. “We see great value in this partnership and are very pleased to have secured this agreement, which will continue to pave the way for future developments that I believe will benefit both companies in creating value.”
"Gilles has been able to string shareholders along for 10+ years"
The stock is up 500% from $.095 to $.57 since he officially became President and CEO. Canadian pharma icon Ronnie Miller from the largest biotech company in the world has joined the company praising Gilles for putting together the pieces for long term growth.